A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation.
Oncology (Williston Park)
; 38(6): 230-231, 2024 06 10.
Article
in En
| MEDLINE
| ID: mdl-38899982
ABSTRACT
Spiradenocarcinomas are rare malignant skin adnexal tumors. We describe a novel case of a patient with an aggressive CDKN2A-mutated spiradenocarcinoma who responded to a CDK4/6 inhibitor. This case highlights the unique nature of spiradenocarcinomas as well as the potential benefit of targeted therapy.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cyclin-Dependent Kinase Inhibitor p16
/
Mutation
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Oncology (Williston Park)
Journal subject:
NEOPLASIAS
Year:
2024
Document type:
Article